Professor peng tee khaw biography of mahatma

Fellow Royal College of Physicians, Royal College of Surgeons, Royal College of Ophthalmology (journal subeditor since ).

Complex adult and pediatric glaucoma, new anti-scarring therapies and novel surgical techniques, and stem cell therapy. Professor and Consultant Eye Surgeon. Since joining Moorfields Eye Hospital in , Sir Peng Tee Khaw has amassed a wealth of awards, experience, and worldwide recognition for his clinical, research, education and philanthropic work.

He has led every successful competitive 5 yearly application for national core funding including the most recent awarded in This was critical as after all previous funding was removed from centers including Moorfields, and only 10 centers received significant core NIHR BRC funding which has kept Moorfields Research and Development viable and growing.

This has led to nearly a hundred publications based on the eye data by many groups around the world and the identification of important roles of genes for glaucoma, myopia and retinal disease, new insights into wider areas like the correlation between cognitive loss and retinal measurements, the effects of pollution on the retina and the use of eye images to accurately predict systemic features like gender and blood pressure using artificial intelligence including key genetic discoveries in Nature Genetics.

Professor Sir Peng Khaw is a world leading glaucoma clinician and surgeon who has received and managed some of the most refractory adult and children's glaucoma from all over the world. He has developed improved techniques for glaucoma surgery. He designed the internationally used Moorfields Safer Surgery System principles including a new application technique for Mitomycin-c which has greatly reduced bleb-related complications and increased the safety of glaucoma surgery.

His antimetabolite application Khaw method was also critical in the successful development of the Preserflo microtube which is now widely used in the UK and Europe. He proposed the audacious goal challenge for glaucoma - intraocular pressure of 10 mmHg lasting 10 years, done in 10 minutes which is getting closer with a combination of a device and more effective anti-scarring strategies to provide a practical solution to the exponentially increasing burden of glaucoma worldwide, particularly in poor and developing countries, due to the rapidly aging population.

Sir Peng Tee Khaw is a Chinese-Malaysian British consultant ophthalmic surgeon at Moorfields Eye Hospital in London, specialising in adult and paediatric glaucoma.

He has developed new surgical instruments Khaw glaucoma surgical instruments and novel direct and indirect gonioscopy lenses Ocular anti-scarring drugs techniques and delivery systems. This includes refining the use of a single dose of beta radiation to prevent scarring and maximize pressure lowering, for which he researched and set the current dose of 10 Gy.

This therapy is now being developed into a novel single second treatment, with a single source that could be used tens of thousands of times. This has shown rescue of the nerve in experimental glaucoma and a Phase a clinical trial is planned.